Microbion

About:

Microbion is a pharmaceutical company developing therapeutics for the treatment of bacterial infections.

Website: http://www.microbioncorp.com

Top Investors: 5N Plus, Cystic Fibrosis Foundation, CARB-X, Quark Venture, Global health sciences venture fund

Description:

Microbion is a pharmaceutical company that focuses on the development of therapeutics for the treatment of bacterial infections. It develops bismuth-thiols to prevent microbial biofilms from forming on medical devices implanted in the body and to prevent microbial biofilms in agricultural crops and industrial surfaces, including ships’ hulls, pulp and paper, and oil industries. It was founded in 1982 and headquartered in Bozeman, Montana.

Total Funding Amount:

$56.4M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Bozeman, Montana, United States

Founded Date:

1982-01-01

Contact Email:

info(AT)microbioncorp.com

Founders:

Brett Baker

Number of Employees:

11-50

Last Funding Date:

2021-03-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai